Greetings on yet another edition of The Prescription!
Patient Safety and Access has been the burning topic of discussion with the Indian government, all policy makers and stakeholders in the health sector. This issue features some interesting read on patient rights, their safety and access through initiatives and policy implementations undertaken by the government, and some FAQs on it.
By 2022, all people up to the age of 30 years will not only get free health check-ups but also free medical treatment. Apart from this major positive announcement by our health minister Shri J P Nadda, the health department is constantly on its toes to keep a check on the antibiotic dose prescribed to patients so to limit its usage. This is being done to mainly address the growth of antimicrobial resistance in the country; all this and more in drug laws and policy injections, pharma injections and national injections.
While doctors have been sentenced for medical negligence; wholesalers and pharmacists have been caught red handed with fake medicines. Get an insight into these Fda actions under drug dopes while reading about AIIMS, Delhi being ranked the number one institute.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
“Budget 2019 proposals for healthcare sector will create a distress-free, functional and comprehensive healthcare and wellness system in the nation encouraging preventive healthcare over curative. A healthy India is the Ninth Dimension of our Vision. We will be aiming at a healthy society with an environment of health assurance and the support of necessary health infrastructure.”
Shri Piyush Goyal,
Finance Minister, GOI
Ghaziabad, February 8, 2019 : The NCC-MvPI successfully conducted the event for launch of MvPI reporting tools to promote Medical Device safety. Event was graced by Dr. G. N. Singh, Secretary-cum-Scientific Director (IPC), Mr. Somnath Basu, Assistant Drugs Controller (CDSCO), Dr. Vinod Arora, Expert IP Review Committee, Dr. N. Murugesan, Director (CDTL, Chennai), Mr. Bejon Misra, International Consumer Policy Expert and Mr. J. L. Sipahimalani, Expert, IP Review committee.
As much as hospitals are places of hope, of second chances and recovery, they can also be the cause of severe anxiety and financial burden for many. When a loved one is seriously ill or injured, we tend to completely trust a hospital and its doctors, without so much as a shadow of a doubt. Now, we are not saying that someone can take advantage of this situation, but it is crucial for everyone to know about their rights at every place.
Medicines Verification System Goes Live Across EU
Brussels, 8 Feb 2019: A ground-breaking new high-tech system to catch falsified medicines in the supply chain in Europe went into effect today, allowing prescription medicines to undergo verification for authenticity before reaching patients.
Novel 'Unclonable' Tag May Help Combat Counterfeiters
London, 8 Feb 2019: Scientists have created an "unclonable" tag that is based on random patterns that can not be replicated even by the manufacturer, an advance that could help prevent identify counterfeit products. Discovering that your new designer handbag or gold watch is a fake is costly and annoying, and counterfeit medical devices or drugs could have even more serious consequences, researchers said.
US FDA Takes New Steps For Improving That Improve Tracking And Tracing Of Medicines
Maryland, 7 Feb 2019: A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality. This means working to ensure greater accountability in our nation’s drug supply chain.
ICH Seeks To Harmonize Generic Drug Standards
Paris, 6 Feb 2019: With an aim to harmonize the technical and scientific standards for generic drugs across borders, the International Council on Harmonization (ICH) on Wednesday released a reflection paper outlining an approach to begin supporting such efforts.
PSM Went To Congress To Share Our Concerns About The Threat Of Counterfeit Medicine
February 8, 2019: On Thursday, January 31, 2019, The Partnership for Safe Medicines (PSM) held briefings for the U.S. House of Representatives and the U.S. Senate in Washington, D.C. to highlight the dangers counterfeit medicines pose to American citizens. Over the course of each three-panel event, congressional staffers learned about the impact that counterfeit medicines have had on individuals and on our local, state, and federal law enforcement officers, and learned about the role of international drug cartels and bad actors in the production and distribution of fake medicine.
A Dozen Americans Opted For Surgeries In Mexico And Ended Up With Antibiotic-Resistant Infections
February 7, 2019: According to The Washington Post, at least a dozen Americans who opted for medical procedures just across the border in Tijuana, Mexico also contracted a rare and potentially deadly strain of bacteria that almost no known antibiotics can treat. One of those patients, Tamika Capone of Jonesboro, Arkansas remains seriously ill four months after her surgery despite doctors treating her with a barrage of drugs, all to no effect.
Frequently Asked Questions
Q1. What is patient access in healthcare?
Ans: In the most basic sense, patient access refers to the ability for patients and their families to take charge of their own health care. This has slowly empowered patients to take control of where and when they receive their medical care. Read More>>>
Digitization Of Manufacturing Sites & Formulation Data On Sugam Portal
Article contributed by Om Prakash Sinha, Bihar
The Drugs Controller General of India (DCGI) has instructed state drug regulators to take necessary action and direct all the manufacturers to upload their manufacturing sites and formulation data on Sugam portal which will strengthen the drug regulatory system by way of improving the transparency, accountability as well as accessibility of the drugs in the country.
Dr. Adarsh Choubey, Senior Resident, Says:PSM-India Newsletter is a 'must read' for all healthcare experts.
Dr. Vanshita Jain, Gynecologist, Says: I have tried many healthcare newsletters and yours is miles ahead of the others. Great Articles! Keep up the good work.
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.